Hermetica Superfood Encyclopedia
The Short Answer
Achyranthes aspera contains oleanolic acid, ecdysteroids, flavonoids, and phenolic acids (including ferulic and caffeic acid) that exert antioxidant, anti-inflammatory, and enzyme-inhibitory effects through free radical scavenging and modulation of enzymes such as acetylcholinesterase (AChE IC50 0.55 mg/ml) and α-glucosidase (IC50 0.80 mg/ml). In vitro studies demonstrate meaningful enzyme inhibition and antioxidant capacity (DPPH IC50 135.8 µg/ml for methanolic leaf extract), though no human clinical trials have yet confirmed therapeutic doses or effect sizes for any indication.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordAchyranthes aspera benefits
Prickly Chaff Flower — botanical close-up
Health Benefits
**Anti-inflammatory Activity**
Flavonoids and phenolic compounds in aerial and root extracts inhibit pro-inflammatory pathways, with traditional use validated by in vitro membrane-disruption and enzyme-inhibition data supporting reduced inflammatory signaling.
**Antioxidant Protection**
Methanolic and infusion extracts demonstrate DPPH radical scavenging (IC50 135.8 µg/ml) and total phenolic content up to 28.86 ± 0.12 mg GAE/g, indicating capacity to neutralize reactive oxygen species implicated in cellular damage.
**Glycemic Enzyme Inhibition**: Extracts inhibit α-amylase (IC50 1
65–1.78 mg/ml) and α-glucosidase (IC50 0.80 mg/ml) in vitro, suggesting a potential role in slowing postprandial glucose absorption relevant to metabolic health support.
**Neuroprotective Potential**: Acetylcholinesterase inhibition (IC50 0
55 mg/ml in methanolic extract) by flavonoid and phenolic constituents may help preserve acetylcholine levels, a mechanism relevant to cognitive support, though this has only been demonstrated in cell-free bioassays.
**Antimicrobial Effects**
Flavonoids and phenolics disrupt microbial cell membranes and generate oxidative stress in pathogens, consistent with traditional use of the plant in wound healing and infection management across African and Ayurvedic folk medicine.
**Skin Condition Management**: Tyrosinase inhibition (IC50 1
90 mg/ml) by polyphenolic fractions indicates potential for managing hyperpigmentation and inflammatory skin conditions, aligning with ethnobotanical applications for dermatological complaints.
**Anthelmintic and Diuretic Use**
Traditional Ayurvedic and African preparations using root decoctions and leaf infusions have long targeted parasitic infections and fluid retention, with phytochemical screening confirming the presence of saponins, alkaloids, and ecdysteroids consistent with these biological activities.
Origin & History
Natural habitat
Achyranthes aspera L. is a pantropical weed native to Africa, Asia, and Australia, widely distributed across sub-Saharan Africa, the Indian subcontinent, and Southeast Asia, where it thrives in disturbed soils, roadsides, and forest margins at varied altitudes. In Africa and India, it grows abundantly as an annual or perennial herb in tropical and subtropical climates, tolerating poor soils with moderate rainfall. The plant is rarely cultivated commercially but is harvested wild; its roots, leaves, seeds, and aerial parts are all utilized in traditional medicine systems across its native range.
“Achyranthes aspera has been used for over two millennia in Ayurvedic medicine, where it is known as 'Apamarga' and referenced in classical texts including the Charaka Samhita for its diuretic, anthelmintic, expectorant, and wound-healing properties, with root ash preparations ('kshara') notably used for dental and skin conditions. Across sub-Saharan Africa, the plant holds significant ethnobotanical value; healers in Nigeria, Ethiopia, Kenya, and South Africa use leaf and root preparations in decoctions for fever, pain, and infection treatment. In South Asian folk practice, the seeds are used as an abortifacient and in rituals, while the leaves are applied topically as poultices for skin conditions and snakebite. The plant's wide pan-tropical distribution and dual role in African and Asian traditional medicine systems make it one of the more cross-culturally documented medicinal weeds, referenced extensively in ethnobotanical surveys across both continents.”Traditional Medicine
Scientific Research
The evidence base for Achyranthes aspera is limited to in vitro phytochemical and bioassay studies, with no published randomized controlled trials, cohort studies, or clinical trials reporting sample sizes, human effect sizes, or validated therapeutic outcomes. Available research consists of qualitative phytochemical screenings (TLC, FTIR, UHPLC-HRMS), total phenolic and flavonoid quantification assays, and cell-free enzymatic inhibition bioassays conducted at laboratory concentrations (e.g., 3 mg/ml for bioassays). Specific quantified outcomes include DPPH IC50 of 135.8 µg/ml for methanolic extract, AChE IC50 of 0.55 mg/ml, α-glucosidase IC50 of 0.80 mg/ml, and TPC of 28.86 ± 0.12 mg GAE/g in infusion extracts, all from in vitro settings that cannot be directly translated to human dosing. The overall evidence quality is preliminary; while mechanistic plausibility is established, the absence of in vivo pharmacokinetic data, bioavailability studies, and human trials means that no therapeutic claims can be substantiated at the clinical level.
Preparation & Dosage
Traditional preparation
**Traditional Decoction (Roots/Leaves)**
5–10 g dried plant material per 200 ml water) and consumed as a decoction; no validated clinical dose established
Root or leaf material boiled in water (typically .
**Methanolic/Ethanolic Extract (Laboratory Standard)**
3 mg/ml in bioassays for enzyme inhibition studies; equivalent human supplemental dose has not been determined
Used at .
**Infusion (Aqueous)**
12 mg GAE/g; traditionally prepared by steeping aerial parts in hot water
Infusion preparations yield TPC of up to 28.86 ± 0..
**Dichloromethane Extract**
48 mg RE/g); used in laboratory fractionation but not suitable as a direct oral preparation
Yields highest total flavonoid content (up to 38.48 ± 1..
**Ethyl Acetate Fraction**
Preferred for flavonoid isolation in research settings; not a commercially standardized form.
**Standardization**
No commercial standardization percentages (e.g., % oleanolic acid or flavonoids) are currently established or validated.
**Timing**
No evidence-based guidance on optimal timing of administration; traditional use is typically with food or water.
Nutritional Profile
Achyranthes aspera is not a dietary staple and does not contribute meaningful macronutrient content; its nutritional significance lies in its phytochemical composition. Key bioactive phytochemicals include: total phenolic content (TPC) of up to 28.86 ± 0.12 mg gallic acid equivalents (GAE)/g in infusion extracts and 9.9 µg/ml GAE in methanolic extracts; total flavonoid content (TFC) up to 38.48 ± 1.48 mg rutin equivalents (RE)/g in dichloromethane extracts; oleanolic acid at 0.54% by weight in root extracts; and specific phenolic acids including ferulic acid and caffeic acid identified via UHPLC-HRMS. Additional compound classes identified include ecdysteroids, alkaloids, glycosides, terpenoids, steroids, tannins, and fatty acids. Bioavailability of these compounds is uncharacterized in humans; polyphenol absorption is generally known to be influenced by gut microbiota transformation, food matrix effects, and conjugation status, none of which have been studied specifically for this plant.
How It Works
Mechanism of Action
The primary antioxidant mechanism involves polyphenols—particularly ferulic acid, caffeic acid, and quercetin-class flavonoids—donating hydrogen atoms to neutralize DPPH and hydroxyl radicals through their hydroxyl-rich aromatic ring structures, as evidenced by DPPH IC50 values of 135.8 µg/ml in methanolic extracts. Enzyme inhibition operates through non-covalent binding of flavonoids and phenolic acids to the active sites of acetylcholinesterase, α-amylase, α-glucosidase, and tyrosinase, with competitive or mixed inhibition kinetics suppressing hydrolytic and oxidative catalytic activity. Oleanolic acid (0.54% in roots) and ecdysteroids modulate nuclear factor signaling pathways associated with inflammation and cellular proliferation, potentially reducing NF-κB-mediated cytokine production. Antimicrobial activity arises from membrane permeabilization by flavonoid aglycones and disruption of electron transport chains in bacterial and fungal cells, a mechanism further amplified by the tannin-mediated precipitation of membrane proteins.
Clinical Evidence
No clinical trials have been conducted on Achyranthes aspera in human subjects, and therefore no evidence-based clinical summary reporting effect sizes, confidence intervals, or validated therapeutic outcomes can be provided. The totality of formal research comprises in vitro enzyme inhibition assays, radical scavenging assays, and phytochemical profiling studies, which establish mechanistic plausibility but do not constitute clinical evidence. Traditional use data from Ayurvedic medicine and African ethnobotany documents applications in pain, inflammation, urinary conditions, and parasitic infections, but these accounts lack standardized outcome measurement. Until well-designed clinical trials with defined extract standardization, dosing regimens, and patient populations are completed, confidence in clinical efficacy remains very low.
Safety & Interactions
The safety profile of Achyranthes aspera in humans is poorly characterized, with no formal clinical toxicology studies, established maximum tolerated doses, or systematic adverse event reporting available. Qualitative phytochemical screenings and limited acute toxicity assessments in laboratory settings have not identified overt acute toxicity at tested concentrations, but the presence of potent bioactive alkaloids, saponins, and ecdysteroids warrants caution at high doses or with prolonged use. Traditional Ayurvedic references note the plant's abortifacient and uterotonic properties in seed preparations, making it contraindicated in pregnancy; lactating women should also avoid use due to insufficient safety data. No formal drug interaction data exists, but the plant's acetylcholinesterase inhibitory activity (IC50 0.55 mg/ml) suggests potential additive or synergistic effects with cholinergic drugs (e.g., donepezil, rivastigmine), and its α-glucosidase inhibition may potentiate hypoglycemic agents; medical supervision is essential before use alongside any pharmaceutical regimen.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Achyranthes aspera L.Prickly Chaff FlowerDevil's HorsewhipApamargaChaff TreeRough Chaff Flower
Frequently Asked Questions
What is Achyranthes aspera used for traditionally?
In Ayurvedic medicine, Achyranthes aspera (known as Apamarga) has been traditionally used for diuretic, anthelmintic, anti-inflammatory, and wound-healing purposes, with root ash preparations applied to skin and dental conditions. Across African folk medicine systems in countries such as Nigeria and Ethiopia, leaf and root decoctions are prepared for fever, pain relief, and infections. These traditional uses are supported by phytochemical evidence of relevant bioactive compounds including alkaloids, saponins, flavonoids, and oleanolic acid, but human clinical trials have not yet validated these applications.
What are the active compounds in Achyranthes aspera?
Achyranthes aspera contains a diverse array of bioactive compounds including oleanolic acid (0.54% in roots), ecdysteroids, flavonoids (TFC up to 38.48 mg RE/g in dichloromethane extracts), phenolic acids such as ferulic acid and caffeic acid, alkaloids, saponins, tannins, terpenoids, steroids, and glycosides. Total phenolic content reaches 28.86 ± 0.12 mg GAE/g in infusion extracts, with concentrations varying significantly by plant part and extraction solvent. These compounds have been identified using modern analytical methods including UHPLC-HRMS, TLC, and FTIR spectroscopy.
Is Achyranthes aspera safe to use?
The safety of Achyranthes aspera in humans is not well established due to the absence of formal clinical toxicology data or human trials. Preliminary laboratory studies have not identified acute toxicity at tested concentrations, but the plant contains potent bioactive alkaloids and saponins that may pose risks at high doses or with prolonged use. Seed preparations have documented uterotonic and abortifacient properties in traditional medicine, making the plant contraindicated during pregnancy, and anyone taking cholinergic or hypoglycemic medications should consult a healthcare provider before use.
Does Achyranthes aspera help with blood sugar control?
In vitro studies show that Achyranthes aspera extracts inhibit α-amylase (IC50 1.65–1.78 mg/ml) and α-glucosidase (IC50 0.80 mg/ml), two key enzymes involved in carbohydrate digestion and postprandial glucose absorption. These results suggest a mechanistic basis for glycemic support, but the research is entirely from cell-free bioassays and has not been validated in animal models or human clinical trials. No supplemental dose for blood sugar management has been established, and individuals with diabetes should not substitute or combine this plant with prescribed medications without medical supervision.
What is the evidence strength for Achyranthes aspera health claims?
The current evidence for Achyranthes aspera is preliminary and limited to in vitro phytochemical studies and enzyme inhibition bioassays; no randomized controlled trials or human clinical studies have been published. Quantified in vitro outcomes such as DPPH IC50 of 135.8 µg/ml and AChE IC50 of 0.55 mg/ml demonstrate mechanistic plausibility, but these laboratory values cannot be directly translated to effective human doses without pharmacokinetic and bioavailability data. Until well-designed clinical trials are conducted, health claims for this ingredient should be considered speculative and grounded primarily in traditional ethnobotanical use.
What forms of Achyranthes aspera are most commonly used in supplements?
Achyranthes aspera is typically available as dried herb powder, standardized extracts, and infusions, with methanolic and aqueous extracts being most studied for bioavailability. The aerial parts and root extracts show different potency profiles, with root extracts generally demonstrating stronger anti-inflammatory activity in research models. Standardized extracts containing quantified levels of flavonoids and phenolic compounds offer more consistent dosing compared to raw herb preparations.
Does Achyranthes aspera interact with anti-inflammatory medications?
Achyranthes aspera contains bioactive compounds that inhibit pro-inflammatory pathways, which could theoretically potentiate the effects of NSAIDs or corticosteroids when used concurrently. While traditional use has been extensive, formal drug-interaction studies are limited, and combining Achyranthes aspera with prescription anti-inflammatory medications should be discussed with a healthcare provider. Caution is warranted, particularly with long-term use of pharmaceutical anti-inflammatories, to avoid excessive pathway inhibition.
Who should avoid taking Achyranthes aspera supplements?
Individuals with bleeding disorders or those taking anticoagulant medications should exercise caution, as some traditional uses suggest blood-thinning properties that require clinical validation. Pregnant and nursing women should avoid Achyranthes aspera due to limited safety data in these populations and its historical use as an emmenagogue in traditional medicine. Additionally, individuals with known allergies to the Amaranthaceae family or those with severe kidney or liver conditions should consult a healthcare provider before supplementation.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w achyranthes-aspera-achyranthes-aspera-l curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
